2023 - Research.com Biology and Biochemistry in South Africa Leader Award
2022 - Research.com Biology and Biochemistry in South Africa Leader Award
His scientific interests lie mostly in Angiogenesis, Endothelial stem cell, Cell biology, Vascular endothelial growth factor and Endocrinology. The subject of his Angiogenesis research is within the realm of Cancer research. Endothelial stem cell is frequently linked to Endothelium in his study.
His Cell biology research is multidisciplinary, incorporating perspectives in Vascular endothelial growth factor C, Lymphatic Endothelium, Morphogenesis and Immunology. His study in Vascular endothelial growth factor is interdisciplinary in nature, drawing from both Basic fibroblast growth factor, Cytokine and Molecular biology. His studies deal with areas such as Proinflammatory cytokine, Internal medicine, Growth factor and Hepatocyte growth factor as well as Endocrinology.
Angiogenesis, Cell biology, Endothelial stem cell, Pathology and Immunology are his primary areas of study. The study incorporates disciplines such as Basic fibroblast growth factor, Endothelium, Vascular endothelial growth factor and Molecular biology in addition to Angiogenesis. As a member of one scientific family, Michael S. Pepper mostly works in the field of Vascular endothelial growth factor, focusing on Endocrinology and, on occasion, Growth factor.
He works mostly in the field of Cell biology, limiting it down to topics relating to Stromal cell and, in certain cases, Adipose tissue, Stem cell and Mesenchymal stem cell, as a part of the same area of interest. Endothelial stem cell and Plasminogen activator are frequently intertwined in his study. His Pathology research includes themes of In vivo and Lymphangiogenesis.
Stem cell, Stromal cell, Cell biology, Adipose tissue and Haematopoiesis are his primary areas of study. His Stem cell research incorporates elements of Embryonic stem cell, Mesenchymal stem cell and Transplantation. His research on Stromal cell concerns the broader Cancer research.
The Cancer research study combines topics in areas such as Platelet, Chronic wound and Molecular medicine. His Cell biology research is multidisciplinary, relying on both Cell, Cell cycle and Cell culture. His work deals with themes such as Transcriptome and Fetal bovine serum, which intersect with Adipose tissue.
His primary scientific interests are in Stem cell, Adipose tissue, Mesenchymal stem cell, Transplantation and Haematopoiesis. His Stem cell study deals with the bigger picture of Cell biology. The concepts of his Cell biology study are interwoven with issues in Cell culture, In vivo and Cytotoxicity.
His Adipose tissue research is multidisciplinary, incorporating elements of Stromal cell, Pathology, Injection site and Rat model. His study in the field of Adipogenesis is also linked to topics like Post injection. His Transplantation study is related to the wider topic of Internal medicine.
Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis
Stefano J. Mandriota;Lotta Jussila;Michael Jeltsch;Amelia Compagni.
The EMBO Journal (2001)
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
M.S. Pepper;N. Ferrara;L. Orci;R. Montesano.
Biochemical and Biophysical Research Communications (1992)
Genistein, a dietary-derived inhibitor of in vitro angiogenesis
Theodore Fotsis;Michael Pepper;Herman Adlercreutz;Gudrun Fleischmann.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Michael S. Pepper.
Arteriosclerosis, Thrombosis, and Vascular Biology (2001)
The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
Theodore Fotsis;Youming Zhang;Michael S. Pepper;Herman Adlercreutz.
Transforming Growth Factor-beta: Vasculogenesis, Angiogenesis, and Vessel Wall Integrity
Michael S Pepper.
Cytokine & Growth Factor Reviews (1997)
Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
M.S. Pepper;N. Ferrara;L. Orci;R. Montesano.
Biochemical and Biophysical Research Communications (1991)
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.
Theodore Fotsis;Michael S. Pepper;Erkan Aktas;Stephen Breit.
Cancer Research (1997)
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells.
Birgitta Olofsson;Eija Korpelainen;Michael S. Pepper;Stefano J. Mandriota.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
Michael Sean Pepper;Dominique Belin;Roberto Montesano;Lelio Orci.
Journal of Cell Biology (1990)
If you think any of the details on this page are incorrect, let us know.